Document is current
Any future updates will be listed below
-
Authors
Abutaleb, Shada
Mallah, Eyad
Abu-Qatouseh, Luay
Abu-awwad, Ahmad
Mansoor, Kenza
Khallad, Sarah
Omari, Khaled W.
Mouhtady, Omar
Arafat, Tawfiq
- License Information
-
More Information
Article History
Received: 27 November 2023
Accepted: 30 January 2025
First Online: 7 March 2025
Declarations
:
: The Helsinki Declaration was followed when conducting the study, the ICH HARMONISED GUIDELINE: INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2) dated November 9, 2016. (ICH 2016). The Jordan Center of Pharmaceutical Research’s Institutional Review Board (IRB) also approved it locally. All individuals and/or their legal representatives gave written informed consent before entering the study. All procedures, interventions, and laboratory tests were conducted per the Jordanian Ministry of Health’s recommendations.
: Not applicable.
: The authors declare no competing interests.
